Humira biosimilars comparison

Biosimilars

Compare adalimumab biosimilars to brand Humira. Multiple biosimilars are now available, and most insurers require them before brand Humira. Products differ primarily in citrate content (injection pain), device design, and copay programs.

Select any two to compare side by side

All products in this comparison

ProductManufacturerRouteFrequencyKey difference
Humira (reference)AbbVieSC injectionEvery 2 weeksOriginal reference product; most clinical data and long-term safety experience
Amjevita (adalimumab-atto)AmgenSC injectionEvery 2 weeksCitrate-free option available; interchangeable biosimilar
Cyltezo (adalimumab-adbm)Boehringer IngelheimSC injectionEvery 2 weeksFirst interchangeable adalimumab biosimilar; citrate-free
Hadlima (adalimumab-bwwd)Samsung BioepisSC injectionEvery 2 weeksCitrate-free formulation available
Hyrimoz (adalimumab-adaz)SandozSC injectionEvery 2 weeksCitrate-free; available in pen and syringe
Yusimry (adalimumab-aqvh)CoherusSC injectionEvery 2 weeksCitrate-free formulation

Related guides

Denied one of these medications?

Ellen can decode your denial letter, identify why you were denied, and generate a personalized appeal, free for patients.